BioCentury | Jul 23, 2015
Tools & Techniques

Gene therapy's coming of age

...GenVec Inc. , Milo Biotechnology LLC , Momotaro-Gene Inc. , MultiVir Inc. , Novartis, PNP Therapeutics Inc....
BioCentury | Dec 9, 2013
Clinical News

AD/PNP-FaraAMP: Phase I ongoing

...of adenovirus plus the 75 mg/m 2 dose of fludarabine in the same dosing schedule. PNP Therapeutics Inc....
Items per page:
1 - 2 of 2
BioCentury | Jul 23, 2015
Tools & Techniques

Gene therapy's coming of age

...GenVec Inc. , Milo Biotechnology LLC , Momotaro-Gene Inc. , MultiVir Inc. , Novartis, PNP Therapeutics Inc....
BioCentury | Dec 9, 2013
Clinical News

AD/PNP-FaraAMP: Phase I ongoing

...of adenovirus plus the 75 mg/m 2 dose of fludarabine in the same dosing schedule. PNP Therapeutics Inc....
Items per page:
1 - 2 of 2